Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition
Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition is a paper indexed in PICO Portal from OpenAlex.
How many citations does Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition have?
Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition has 46 citations in the OpenAlex counts PICO Portal stores.
When was Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition published?
Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition has 2022 year in the PICO Portal index.
What is the open-access status of Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition?
Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition has closed oa status in the PICO Portal index.
What is the DOI of Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition?
The DOI for Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition is on the source record.
What is the PMID of Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition?
The PMID for Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition is on the source record.
What is the OpenAlex record for Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition?
The OpenAlex for Diosmetin alleviates cerebral ischemia‐reperfusion injury through Keap1‐mediated Nrf2/<scp>ARE</scp> signaling pathway activation and <scp>NLRP3</scp> inflammasome inhibition is on the source record.